Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS) - Pilot Study

NCT00816907 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00816907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00816907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS) - Pilot Study
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2010
Enrollment
146 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia